| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31. | J Natl Cancer Inst | 2013 | 2.28 |
| 2 | Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancer. | J Clin Oncol | 2011 | 1.32 |
| 3 | Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trials. | Clin Cancer Res | 2008 | 1.13 |
| 4 | Inflammatory myofibroblastic tumor of the small bowel mesentery: an unusual cause of abdominal pain and uveitis. | J Gastrointest Surg | 2011 | 0.96 |
| 5 | Tumor associated macrophages in relapsed and refractory Hodgkin lymphoma. | Leuk Res | 2013 | 0.81 |
| 6 | Rhabdomyomatous mesenchymal hamartoma mimicking basal cell carcinoma. | Am J Dermatopathol | 2009 | 0.80 |
| 7 | Fixation time and HER2/neu assessment. | Am J Clin Pathol | 2011 | 0.75 |